These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18991190)

  • 1. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.
    Sidiropoulos PI; Siakka P; Pagonidis K; Raptopoulou A; Kritikos H; Tsetis D; Boumpas DT
    Scand J Rheumatol; 2009; 38(1):6-10. PubMed ID: 18991190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
    Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.
    Gonzalez-Juanatey C; Llorca J; Sanchez-Andrade A; Garcia-Porrua C; Martin J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2006; 24(3):309-12. PubMed ID: 16870100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.
    Kerekes G; Soltész P; Dér H; Veres K; Szabó Z; Végvári A; Szegedi G; Shoenfeld Y; Szekanecz Z
    Clin Rheumatol; 2009 Jun; 28(6):705-10. PubMed ID: 19319624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody.
    Gonzalez-Juanatey C; Testa A; Garcia-Castelo A; Garcia-Porrua C; Llorca J; Gonzalez-Gay MA
    Arthritis Rheum; 2004 Jun; 51(3):447-50. PubMed ID: 15188332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.
    Turiel M; Tomasoni L; Sitia S; Cicala S; Gianturco L; Ricci C; Atzeni F; De Gennaro Colonna V; Longhi M; Sarzi-Puttini P
    Cardiovasc Ther; 2010 Oct; 28(5):e53-64. PubMed ID: 20337633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis.
    Veselinovic MV; Zivkovic VI; Toncev S; Tasic N; Bogdanovic V; Djuric DM; Jakovljevic VLj
    Vasa; 2012 Sep; 41(5):343-51. PubMed ID: 22915531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.
    Hürlimann D; Forster A; Noll G; Enseleit F; Chenevard R; Distler O; Béchir M; Spieker LE; Neidhart M; Michel BA; Gay RE; Lüscher TF; Gay S; Ruschitzka F
    Circulation; 2002 Oct; 106(17):2184-7. PubMed ID: 12390945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.
    Del Porto F; Laganà B; Lai S; Nofroni I; Tinti F; Vitale M; Podestà E; Mitterhofer AP; D'Amelio R
    Rheumatology (Oxford); 2007 Jul; 46(7):1111-5. PubMed ID: 17449484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Kaur L; Sharma S
    Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study.
    Bartelds GM; Wijbrandts CA; Nurmohamed MT; Stapel S; Lems WF; Aarden L; Dijkmans BA; Tak PP; Wolbink GJ
    Ann Rheum Dis; 2010 May; 69(5):817-21. PubMed ID: 19581278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis.
    Watanabe T; Takemura M; Sato M; Matsunami H; Seishima M; Shimizu K; Matsuoka T
    Int J Rheum Dis; 2014 Jan; 17(1):26-33. PubMed ID: 24472263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
    Galarraga B; Belch JJ; Pullar T; Ogston S; Khan F
    J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy.
    González-Gay MA; González-Juanatey C; Miranda-Filloy JA; García-Unzueta MT; Llorca J
    Acta Reumatol Port; 2012; 37(2):155-9. PubMed ID: 23149638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial dysfunction and early atherosclerosis in non-differentiated collagenosis].
    Kerekes G; Bodolay E; Sipka S; Szomják E; Veres K; Zeher M; Szegedi G; Soltész P
    Orv Hetil; 2005 Apr; 146(17):791-5. PubMed ID: 17918635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis.
    Couderc M; Payet S; Henquell C; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):414-7. PubMed ID: 20542718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
    Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.
    Bosello S; Santoliquido A; Zoli A; Di Campli C; Flore R; Tondi P; Ferraccioli G
    Clin Rheumatol; 2008 Jul; 27(7):833-9. PubMed ID: 18075712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.